Optimized curcumin for enhanced absorption with vegan D3*
- Formulated for slow breakdown
- High-dose, optimized curcumin from turmeric
- Remains in the bloodstream for up to 24 hours
$99.96 — subscription plans starting at $99.96 / month
The CurcuMIND™ formula includes vitamin D3, which benefits the body by providing support to the immune system, promoting proper calcium absorption for healthy bones, and helping to balance mood. The synergistic combination of one of the most absorbable, effective curcumins with vitamin D3 offers powerful antioxidants and promotes both a healthy inflammatory response and balanced immune support.
AOR’s formula contains Longvida® which has been shown to be one of the most absorbable and effective curcumins on the market. It is also one of the only curcumins shown to yield curcumin in the bloodstream that is free from a rapid breakdown, allowing it to cross the blood-brain barrier. This makes Longvida® one of the most effective curcumin providing support for brain health.
CurcuMIND™ is a vegan supplement that provides a combination of optimized curcumin and vitamin D3 that promotes a healthy immune system while providing support for mood, cognitive function, and brain health.
CurcuMIND™ provides vegan vitamin D3 sourced from lichen, and is combined with a high dose of Longvida® a novel form of curcumin resistant to breakdown. Combined to support healthy cognitive function.*
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, dairy, eggs, fish, shellfish or any animal byproduct.
Take one capsule one to three times daily with/without food, or as directed by a qualified health care practitioner.
Consult a health care practitioner before use if you’re pregnant, lactating, have a medical condition, or if you’re taking any medication (like blood thinners). Keep out of reach of children.
- Cognitive health
- Inflammatory response support
- Cellular growth and differentiation
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
(from Curcuma longa root) ‡
† Daily Value not established
* Longvida® is a registered trademark of Verdure Sciences Inc. International patent pending.
Other Ingredients: tapioca dextrin, stearic acid, maltodextrin, soy lecithin, ascorbyl palmitate, silicon dioxide and sodium stearyl fumarate.
Capsule: hypromellose and purified water.
Baum et al. Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease. Journal of Clinical Psychopharmacology. 2008; 28(1): 110-113.
Begum AN et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease. J Pharmacol Exp Ther. 2008 Jul;326(1):196-208
Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol. 2014 Oct 2.
Fiala M, Mahanian M, Rosenthal M, Mizwicki MT, Tse E, Cho T, Sayre J, Weitzman R, Porter V. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer’s disease by vitamin D and curcuminoids. J Alzheimers Dis. 2011;25(1):135-44.
Frautschy, SA. 38th Annual Meeting of the Society of Neuroscience , Washington DC, November 15, 2008.
Gota VS et al. Safety and Pharmacokinetics of a Solid Lipid Curcumin Particle Formulation in Osteosarcoma Patients and Healthy Volunteers. J Agric Food Chem. 2010; 58(4): 2095-2099.
Hamaguchi T et al. REVIEW: Curcumin and Alzheimer’s Disease. CBS Neuroscience and Therapeutics. 2010; 16(5): 285-297.
Haussler MR et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutrition Reviews. 2008; 68: S98-S112.
Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2009;17(3):703-17.
Ray B, Lahiri DK. Neuroinflammation in Alzheimer’s disease: different molecular targets and potential therapeutic agents including curcumin. Curr Opin Pharmacol. 2009 Aug;9(4):434-44.